TG Therapeutics, Inc. (TGTX) NASDAQ

31.20

+3.33(+11.95%)

Updated at January 14 09:40AM

Currency In USD

Valuation

Market Cap4.37B
Enterprise Value4.45B
P/E Ratio9.06
PEG Ratio0.01
Price/Sales Ratio8.32
Price/Book Ratio6.67
Enterprise/Revenue8.66
Enterprise/EBITDA39.95

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.84
Operating Margin0.19

Management Effectiveness

Return On Assets0.44
Return On Equity1.33

Income Statement

Revenue329M
Revenue/Share3.66
Gross Profit290.52M
EBITDA49.9M
Net Income23.38M
Diluted EPS0.15

Balance Sheet

Total Cash131.58M
Total Cash/Share0.9
Total Debt253.72M
Total Debt/Equity0.42
Current Ratio3.82
Book Value Per Share4.18

Price History

52-Week Change-6.29
52-Week High46.48
52-Week Low25.28
Moving Average 50 Days31.11
Moving Average 200 Days34.1

Statistics

Average Volume1.86M
Shares Outstanding158.76M
% Held by Institutions67.47

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor4:225
Last Split DateApril 30, 2012